InMed Pharmaceuticals Inc INM Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	12.79M	14.58M	16.92M	14.73M	14.11M	10.92M	15.26M	13.36M
Total Current Assets	9.6M	11.54M	14.02M	11.84M	11.33M	8.3M	11.81M	10.06M
Cash and Equivalents	6.18M	9.35M	11.45M	9.6M	8.91M	6.74M	9.54M	7.6M
Total Non-Current Assets	4.09M	3.84M	3.61M	3.64M	3.5M	3.24M	1.78M	4.67M
Total Liabilities	3.71M	3.58M	2.58M	2.34M	2.02M	1.34M	2.48M	2.25M
Total Current Liabilities	3.32M	3.28M	2.4M	2.27M	2M	1.34M	1.68M	1.53M
Total Non-Current Liabilities	778k	588k	366k	74k	32k	0	1.61M	1.45M
Common Equity	70.72M	72.67M	74.86M	113.32M	77.62M	77.62M	79.94M	80.61M
Retained Earnings	-93.45M	-96.96M	-99.06M	-101.06M	-101.4M	129k	-105.42M	-107.14M

Year End June 29 2023	2016	2017	2018	2019	2020	2021	2022	2023
	CAD ($)	CAD ($)	CAD ($)	CAD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.57M	8.34M	28.06M	19.79M	7.8M	9.78M	12.79M	14.11M
Total Current Assets	187k	6.94M	26.73M	18.55M	6.31M	8.38M	9.6M	11.33M
Cash and Equivalents	54k	6.71M	24.13M	12.87M	5.81M	7.36M	6.18M	8.91M
Total Non-Current Assets	984k	7.97M	27.13M	18.23M	5.88M	7.38M	9.08M	12.09M
Total Liabilities	590k	369k	938k	1.56M	1.93M	2.41M	3.71M	2.02M
Total Current Liabilities	590k	369k	938k	1.56M	1.68M	2.22M	3.32M	2M
Total Non-Current Liabilities	0	0	0	0	498k	380k	778k	32k
Total Equity	984k	7.97M	27.13M	18.23M	5.88M	7.38M	9.08M	12.09M
Common Equity	32.74M	43.15M	68.06M	68.58M	53.07M	60.59M	70.72M	77.62M
Retained Earnings	-38.32M	-42.79M	-51.32M	-64.57M	-64.65M	-74.85M	-93.45M	-101.4M